Hormone replacement therapy and high incidence of breast cancer between mammographic screens
Schouten, L.J.; de Rijke, J.M.; Schlangen, J.T.; Verbeek, A.L.
Lancet 349(9058): 1104
1997
ISSN/ISBN: 0140-6736 PMID: 9107274 Document Number: 471808
Document emailed within 1 workday
Related Documents
Jørgensen, K.Juhl. 2004: Pronounced differences in the estimation of breast cancer mortality in connection with hormone replacement therapy and mammographic screening Ugeskrift for Laeger 166(15-16): 1465Cobleigh, M.A.; Norlock, F.E.; Oleske, D.M.; Starr, A. 1999: Hormone replacement therapy and high S phase in breast cancer JAMA 281(16): 1528-1530
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Fentiman, I.S. 2002: 20. Oral contraceptives, hormone replacement therapy and breast cancer International Journal of Clinical Practice 56(10): 755-759
Snyder, G.M.; Sielsch, E.C.; Reville, B. 1998: The controversy of hormone-replacement therapy in breast cancer survivors Oncology Nursing Forum 25(4): 699-706; Quiz: 707-708
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
This, P. 1996: Hormone replacement therapy in menopausal women previously treated for breast cancer Presse Medicale 25(4): 141-144
Ratanawichitrasin, A.; Reansuwan, W.; Ratanawichitrasin, S.; Bhodhisuwan, K.; Kongpatanakul, S. 2002: Risk of breast cancer in post-menopausal women using hormone replacement therapy Journal of the Medical Association of Thailand 85(5): 583-589
Barda, L.; Nevler, A.; Rosin, D.; Shabtai, E.L.; Gutman, M.; Shabtai, M. 2019: The effects of Hormonal Replacement Therapy (Hrt) on Mammographic Breast Density and Abnormal Mammograms Prompting Further Investigation Harefuah 158(4): 239-243
Nachtigall, M.J.; Smilen, S.W.; Nachtigall, R.D.; Nachtigall, R.H.; Nachtigall, L.E. 1992: Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy Obstetrics and Gynecology 80(5): 827-830
Tangkaratt, S. 2004: Mammographic findings in breast cancer patients, who were treated with breast conserving therapy Journal of the Medical Association of Thailand 87(12): 1439-1443
Genazzani, A.; Gambacciani, M.; Simoncini, T.; Anniverno, R.; Becorpi, A.M.; Biglia, N.; Brandi, M.L.; Guaschino, S.; Lello, S.; Massobrio, M.; Melis, G.B.; Mencacci, C.; Modena, M.G.; Nappi, C.; Nappi, R.E.; Pecorelli, S.; Petraglia, F.; Rosano, G.M.; Serra, G.B.; Sismondi, P.; Taddei, S.; Tonelli, F. 2007: Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007 Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 23(8): 436-444
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518
Kubota, O.; Onuki, Y.; Uchiyama, T.; Oishi, K.; Takeda, M. 2012: Efficacy of high-dose toremifene as a second-line hormone therapy in patients with advanced or metastatic breast cancer resistant to aromatase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 753-757
Rookus, M.A.; van Leeuwen, F.E.; Hamerlynck, J.V. 1998: Last word on hormone replacement and breast cancer? Nederlands Tijdschrift Voor Geneeskunde 142(3): 111-113
Fiorica, J. 2001: Association between changes in hormone replacement therapy and breast density JAMA 285(14): 1839-1840
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Gadducci, A.; Guerrieri, M.E.; Genazzani, A.R. 2012: Benign breast diseases, contraception and hormone replacement therapy Minerva Ginecologica 64(1): 67-74